Gary L. Clayman

ORCID: 0000-0002-2746-0387
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Thyroid Cancer Diagnosis and Treatment
  • Head and Neck Cancer Studies
  • Cancer-related Molecular Pathways
  • Virus-based gene therapy research
  • Thyroid and Parathyroid Surgery
  • Nonmelanoma Skin Cancer Studies
  • Salivary Gland Tumors Diagnosis and Treatment
  • Cancer Research and Treatments
  • Head and Neck Surgical Oncology
  • Ear and Head Tumors
  • Cell Adhesion Molecules Research
  • Protease and Inhibitor Mechanisms
  • Genetic factors in colorectal cancer
  • Skin and Cellular Biology Research
  • Head and Neck Anomalies
  • Cancer Genomics and Diagnostics
  • Cancer Diagnosis and Treatment
  • RNA Interference and Gene Delivery
  • Cutaneous Melanoma Detection and Management
  • Tumors and Oncological Cases
  • NF-κB Signaling Pathways
  • BRCA gene mutations in cancer
  • Tracheal and airway disorders
  • Chemokine receptors and signaling
  • Immunotherapy and Immune Responses

Tampa General Hospital
2016-2024

The University of Texas MD Anderson Cancer Center
2009-2023

University of Michigan
2011-2023

York University
2023

University of Pittsburgh Medical Center
2023

University of Colorado Health
2023

UPMC Health System
2023

Cornell University
2023

Tokyo Medical and Dental University
2023

AdventHealth Tampa
2022

Nishant Agrawal Rehan Akbani Bülent Arman Aksoy Adrian Ally Harindra Arachchi and 95 more L. Sylvia J. Todd Auman Miruna Balasundaram Saianand Balu Stephen B. Baylin Madhusmita Behera Brady Bernard Rameen Beroukhim Justin A. Bishop Aaron D. Black Tom Bodenheimer Lori Boice Arnoud Boot Jay Bowen Reanne Bowlby Christopher A. Bristow Robin Brookens Denise Brooks Robert Bryant Elizabeth Buda Yaron S.N. Butterfield Tobias Carling Rebecca Carlsen Scott L. Carter Sally E. Carty Timothy A. Chan Amy Y. Chen Andrew D. Cherniack Dorothy Cheung Lynda Chin Juok Cho Andy Chu Eric Chuah Kristian Cibulskis Giovanni Ciriello Amanda Clarke Gary L. Clayman Leslie Cope John A. Copland Kyle R. Covington Ludmila Danilova Tanja M. Davidsen John A. Demchok Daniel DiCara Noreen Dhalla Rajiv Dhir Sheliann S. Dookran Gideon Dresdner Jonathan Eldridge Greg Eley Adel K. El‐Naggar Stephanie Eng James A. Fagin Timothy R. Fennell Robert L. Ferris Sheila Fisher Scott Frazer Jessica Frick Stacey Gabriel Ian Ganly Jianjiong Gao Levi A. Garraway Julie M. Gastier-Foster Gad Getz Nils Gehlenborg Ronald Ghossein Richard A. Gibbs Thomas J. Giordano Karen Gomez-Hernandez Jonna Grimsby Benjamin Groß Ranabir Guin Angela Hadjipanayis Hollie A. Harper D. Neil Hayes David I. Heiman James G. Herman Katherine A. Hoadley Matan Hofree Robert A. Holt Alan P. Hoyle Franklin W. Huang Mei Huang Carolyn M. Hutter Trey Ideker Lisa Iype Anders J. Skanderup Joshua M. Stuart Corbin D. Jones Steven J.M. Jones L. Sylvia Electron Kebebew Fadlo R. Khuri Jaegil Kim Roger Kramer

<h2>Summary</h2> Papillary thyroid carcinoma (PTC) is the most common type of cancer. Here, we describe genomic landscape 496 PTCs. We observed a low frequency somatic alterations (relative to other carcinomas) and extended set known PTC driver include <i>EIF1AX</i>, <i>PPM1D</i>, <i>CHEK2</i> diverse gene fusions. These discoveries reduced fraction cases with unknown oncogenic from 25% 3.5%. Combined analyses variants, expression, methylation demonstrated that different groups lead...

10.1016/j.cell.2014.09.050 article EN cc-by-nc-nd Cell 2014-10-01

Abstract Purpose: Aggressive cutaneous squamous cell carcinoma (cSCC) is often a disfiguring and lethal disease. Very little currently known about the mutations that drive aggressive cSCC. Experimental Design: Whole-exome sequencing was performed on 39 cases of cSCC to identify driver genes novel therapeutic targets. Significantly, mutated were identified with MutSig or complementary methods developed specifically candidate tumor suppressors based upon their inactivating mutation bias....

10.1158/1078-0432.ccr-14-1768 article EN cc-by Clinical Cancer Research 2014-10-11

Purpose To identify nonmelanoma skin cancer patients with squamous cell carcinoma (SCC) who are at greatest risk of disease-specific mortality. Patients and Methods Prospectively enrolled a minimum one pathologically confirmed SCC lesion, definitive treatment the lesion(s) resulting in no evidence disease, least 2 months follow-up after were eligible for present longitudinal analysis. They received comprehensive clinical, pathologic evaluations patterns failure Results We 210 (187 men 23...

10.1200/jco.2005.02.155 article EN Journal of Clinical Oncology 2005-01-29

Intracranial complications of paranasal sinusitis constitute true surgical and medical emergencies. The charts all patients (n = 649) admitted for acute or chronic to the University Minnesota Hospital Michigan Medical Center during a 13-year period (1975 1988) were retrospectively reviewed determine incidence complications. clinical presentation, bacteriology, involved sinuses, influencing host factors, white blood cell count on length hospitalization, postinterventional are presented....

10.1288/00005537-199103000-00003 article EN The Laryngoscope 1991-03-01

Abstract Purpose: Human cell lines are useful for studying cancer biology and preclinically modeling therapy, but can be misidentified cross-contamination is unfortunately common. The purpose of this study was to develop a panel validated head neck representing the spectrum tissue sites histologies that could used molecular, genetic, phenotypic diversity cancer. Methods: A 122 clinically phenotypically diverse from squamous carcinoma, thyroid cancer, cutaneous adenoid cystic oral...

10.1158/1078-0432.ccr-11-0690 article EN Clinical Cancer Research 2011-08-26

Abstract Purpose: Thyroid cancer cell lines are valuable models but have been neglected in pancancer genomic studies. Moreover, their misidentification has a significant problem. We aim to provide validated dataset for thyroid researchers. Experimental Design: performed next-generation sequencing (NGS) and analyzed the transcriptome of 60 authenticated compared our findings with known defects human cancers. Results: Unsupervised transcriptomic analysis showed that 94% clustered distinctly...

10.1158/1078-0432.ccr-18-2953 article EN Clinical Cancer Research 2019-02-08

Anaplastic thyroid carcinoma is arguably the most lethal human malignancy. It often co-occurs with differentiated cancers, yet molecular origins of its aggressivity are unknown. We sequenced tumor DNA from 329 regions cancer, including 213 patients primary anaplastic carcinomas. also whole genome 9 using multi-region sequencing both and cancer components. Using these data, we demonstrate thatanaplastic carcinomas have a higher burden mutations than other distinct mutational signatures...

10.1016/j.celrep.2024.113826 article EN cc-by-nc-nd Cell Reports 2024-02-26

PURPOSE Standard therapies of head and neck squamous cell carcinoma (HNSCC) often cause profound morbidity have not significantly improved survival over the last 30 years. Preclinical studies showed that adenoviral vector delivery wild-type p53 gene reduced tumor growth in mouse xenograft models. Our purpose was to ascertain safety therapeutic potential (Ad)-p53 advanced HNSCC. PATIENTS AND METHODS Patients with incurable recurrent local or regionally metastatic HNSCC received multiple...

10.1200/jco.1998.16.6.2221 article EN Journal of Clinical Oncology 1998-06-01

Because reduced DNA repair capacity (phenotype) has been suggested as a risk factor for squamous cell carcinoma of the head and neck (SCCHN), newly-identified gene polymorphisms (genotype) may also be implicated in risk. To test this hypothesis, we conducted case-control study 203 SCCHN patients 424 control subjects (matched age, sex ethnicity) to investigate role two XRCC1 ( 26304 T 28152 A, respectively) SCCHN. Multivariate logistic regression analysis was performed calculate adjusted odds...

10.1093/carcin/20.11.2125 article EN Carcinogenesis 1999-11-01

Because parathyroid carcinoma is rare, clear consensus not available regarding the optimal management of patients with this condition. Treatment strategies generally derive from clinical and anecdotal experiences. We report our experience entity.We included all seen at The University Texas M. D. Anderson Cancer Center since January 1, 1980. medical records pathology specimens were reviewed verified in cases.Since 1980, 27 (16 men 11 women) registered a minimum follow-up 2 years. age initial...

10.1002/hed.20049 article EN Head & Neck 2004-07-09

Abstract Objective/Hypothesis: Cutaneous squamous cell carcinoma (CSCC) has been reported to metastasize parotid and cervical lymph nodes. Few prospective investigations of associated clinical histopathologic findings their effect on patient outcomes exist. We seek identify risk factors for nodal metastases in CSCC determine the impact lymphatic spread survival recurrence. Study Design: Subset analysis a prospective, longitudinal database patients with at comprehensive cancer center....

10.1097/01.mlg.0000173202.56739.9f article EN The Laryngoscope 2005-09-01

Desquamation of the stratum corneum is a serine protease-dependent process. Two members human tissue kallikrein (KLK) family (chymo)tryptic-like proteases, KLK5 and KLK7, are implicated in desquamation by digestion (corneo)desmosomes inhibition desquamation-related protease inhibitors (SPIs). However, epidermal localization specificity additional KLKs also supports role for these enzymes desquamation. This study aims to delineate probable contribution KLK1, KLK5, KLK6, KLK13, KLK14 examining...

10.1074/jbc.m607567200 article EN cc-by Journal of Biological Chemistry 2006-12-12

Abstract BRAK/CXCL14 is a CXC chemokine constitutively expressed at the mRNA level in certain normal tissues but absent from many established tumor cell lines and human cancers. Although multiple investigators cloned BRAK, little known regarding physiologic function of BRAK or reason for decreased expression cancer. To understand possible significance associated with loss tumors, we examined pattern protein specimens patients squamous carcinoma (SCC) tongue used recombinant (rBRAK) to...

10.1158/0008-5472.can-04-2056 article EN Cancer Research 2004-11-15

To evaluate the clinical potential of fluorescence spectroscopy (a noninvasive technique for assessing chemical and morphologic composition tissue) in vivo detection oral cavity neoplasia.A system recorded spectra from sites 8 healthy volunteers 15 patients with premalignant or malignant lesions at 337-, 365-, 410-nm excitation wavelengths emission range 350 to 700 nm. Fluorescence peak intensities spectral line shapes were compared diagnostic algorithms developed distinguish normal abnormal...

10.1001/archotol.124.11.1251 article EN Archives of Otolaryngology - Head and Neck Surgery 1998-11-01

Sinonasal neuroendocrine tumors are rare malignancies that represented by a spectrum of histologies, including esthesioneuroblastoma (ENB), sinonasal undifferentiated carcinoma (SNUC), (NEC), and small cell (SmCC). The authors reviewed their institutional experience to determine whether different histologies have distinct clinical characteristics warrant individualized treatment approaches.The treated 72 adults with pathologically proven, nonmetastatic, primary from 1982 2002. There were 31...

10.1002/cncr.20693 article EN Cancer 2004-10-29

Background: Ultrasound (US) of the central neck compartment (CNC) is considered limited sensitivity for nodal spread in papillary thyroid cancer (PTC); elective dissection commonly advocated even absence sonographic abnormalities. We hypothesized that US an accurate predictor long-term disease-free survival, regardless use patients with PTC. Methods: A retrospective chart review 331 consecutive PTC treated total thyroidectomy at M.D. Anderson Cancer Center between 1996 and 2003 was...

10.1089/thy.2011.0121 article EN Thyroid 2012-01-26
Coming Soon ...